1. Home
  2. APLT vs RAVE Comparison

APLT vs RAVE Comparison

Compare APLT & RAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • RAVE
  • Stock Information
  • Founded
  • APLT 2016
  • RAVE 1958
  • Country
  • APLT United States
  • RAVE United States
  • Employees
  • APLT N/A
  • RAVE N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • RAVE Restaurants
  • Sector
  • APLT Health Care
  • RAVE Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • RAVE Nasdaq
  • Market Cap
  • APLT 44.0M
  • RAVE 39.1M
  • IPO Year
  • APLT 2019
  • RAVE N/A
  • Fundamental
  • Price
  • APLT $0.39
  • RAVE $2.80
  • Analyst Decision
  • APLT Buy
  • RAVE
  • Analyst Count
  • APLT 7
  • RAVE 0
  • Target Price
  • APLT $6.10
  • RAVE N/A
  • AVG Volume (30 Days)
  • APLT 2.4M
  • RAVE 25.4K
  • Earning Date
  • APLT 08-06-2025
  • RAVE 05-08-2025
  • Dividend Yield
  • APLT N/A
  • RAVE N/A
  • EPS Growth
  • APLT N/A
  • RAVE 25.31
  • EPS
  • APLT N/A
  • RAVE 0.19
  • Revenue
  • APLT $265,000.00
  • RAVE $12,240,000.00
  • Revenue This Year
  • APLT $1,768.13
  • RAVE N/A
  • Revenue Next Year
  • APLT $292.85
  • RAVE N/A
  • P/E Ratio
  • APLT N/A
  • RAVE $15.05
  • Revenue Growth
  • APLT N/A
  • RAVE 3.35
  • 52 Week Low
  • APLT $0.30
  • RAVE $1.70
  • 52 Week High
  • APLT $10.62
  • RAVE $3.36
  • Technical
  • Relative Strength Index (RSI)
  • APLT 51.68
  • RAVE 64.71
  • Support Level
  • APLT $0.32
  • RAVE $2.48
  • Resistance Level
  • APLT $0.36
  • RAVE $2.91
  • Average True Range (ATR)
  • APLT 0.03
  • RAVE 0.11
  • MACD
  • APLT 0.00
  • RAVE 0.03
  • Stochastic Oscillator
  • APLT 73.78
  • RAVE 86.62

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The company-owned restaurant segment includes sales and operating results for all company-owned restaurants. The Pizza Inn Franchising segment accounts for the company's revenue. Geographically, it generates the majority of the revenue from the United States.

Share on Social Networks: